Eurofins CDMO (Contract Development & Manufacturing Organization) offers a complete drug development package for new chemical and biologic entities starting in preclinical development up to early clinical until the production of small commercial batches to third parties to help them speeding up the development and manufacturing or their drugs. We are specialized in the development of innovative formulation technologies serving solutions to enhance bioavailability and control drug release for difficult-to-formulate drug candidates.
Eurofins CDMO is also present in the fields of generic drug product development and manufacturing as well as Life Cycle Management of existing drugs.
We offer a wide range of drug product development and manufacturing technologies to produce liquid, solid and semi-solid dosage forms for oral, nasal, buccal and topical delivery. The developed drug products can be scaled-up for clinical trial manufacturing.
With more than two decades of development and manufacturing experience and 5 state-of-the-art facilities worldwide, Eurofins CDMO provides high-quality, customized solutions for complex products and unique production processes, specializing in the development of innovative formulations.
Choose Eurofins CDMO to help you:
✔ Accelerate preclinical and clinical phases of your chemical or biological product with easy scale-up and smooth transfer from development to GMP facilities
✔ Clinical trial manufacturing of non-sterile liquid, semi-solid and solid dosage forms
✔ Manufacture immediate and controlled release delivery systems
✔ Bi-layered tablets
✔ Release and stability evaluation (Accelerated stability, ICH stability, ASAP) of manufactured drug products
✔ Commercial manufacturing (small commercial batches and Orphan Drugs)